Charmaine S Tam1, Leanne M Redman1, Frank Greenway1, Karl A LeBlanc1, Mark G Haussmann1, Eric Ravussin1. 1. Charles Perkins Centre and School of Life and Environmental Sciences (C.S.T.), The University of Sydney, Sydney, NSW 2006, Australia; Pennington Biomedical Research Center (C.S.T., L.M.R., F.G., E.R.), Baton Rouge, Louisiana 70808; and Our Lady of the Lake Physician Group (K.A.L., M.G.H.), Baton Rouge, Louisiana 70808.
Abstract
CONTEXT: It is not known whether the magnitude of metabolic adaptation, a greater than expected drop in energy expenditure, depends on the type of bariatric surgery and is associated with cardiometabolic improvements. OBJECTIVE: To compare changes in energy expenditure (metabolic chamber) and circulating cardiometabolic markers 8 weeks and 1 year after Roux-en-y bypass (RYGB), sleeve gastrectomy (SG), laparoscopic adjustable gastric band (LAGB), or a low-calorie diet (LCD). Design, Setting, Participants, and Intervention: This was a parallel-arm, prospective observational study of 30 individuals (27 females; mean age, 46 ± 2 years; body mass index, 47.2 ± 1.5 kg/m2) either self-selecting bariatric surgery (five RYGB, nine SG, seven LAGB) or on a LCD (n = 9) intervention (800 kcal/d for 8 weeks, followed by weight maintenance). RESULTS: After 1 year, the RYGB and SG groups had similar degrees of body weight loss (33-36%), whereas the LAGB and LCD groups had 16 and 4% weight loss, respectively. After adjusting for changes in body composition, 24-hour energy expenditure was significantly decreased in all treatment groups at 8 weeks (-254 to -82 kcal/d), a drop that only persisted in RYGB (-124 ± 42 kcal/d; P = .002) and SG (-155 ± 118 kcal/d; P = .02) groups at 1 year. The degree of metabolic adaptation (24-hour and sleeping energy expenditure) was not significantly different between the treatment groups at either time-point. Plasma high-density lipoprotein and total and high molecular weight adiponectin were increased, and triglycerides and high-sensitivity C-reactive protein levels were reduced 1 year after RYGB or SG. CONCLUSIONS: Metabolic adaptation of approximately 150 kcal/d occurs after RYGB and SG surgery. Future studies are required to examine whether these effects remain beyond 1 year.
CONTEXT: It is not known whether the magnitude of metabolic adaptation, a greater than expected drop in energy expenditure, depends on the type of bariatric surgery and is associated with cardiometabolic improvements. OBJECTIVE: To compare changes in energy expenditure (metabolic chamber) and circulating cardiometabolic markers 8 weeks and 1 year after Roux-en-y bypass (RYGB), sleeve gastrectomy (SG), laparoscopic adjustable gastric band (LAGB), or a low-calorie diet (LCD). Design, Setting, Participants, and Intervention: This was a parallel-arm, prospective observational study of 30 individuals (27 females; mean age, 46 ± 2 years; body mass index, 47.2 ± 1.5 kg/m2) either self-selecting bariatric surgery (five RYGB, nine SG, seven LAGB) or on a LCD (n = 9) intervention (800 kcal/d for 8 weeks, followed by weight maintenance). RESULTS: After 1 year, the RYGB and SG groups had similar degrees of body weight loss (33-36%), whereas the LAGB and LCD groups had 16 and 4% weight loss, respectively. After adjusting for changes in body composition, 24-hour energy expenditure was significantly decreased in all treatment groups at 8 weeks (-254 to -82 kcal/d), a drop that only persisted in RYGB (-124 ± 42 kcal/d; P = .002) and SG (-155 ± 118 kcal/d; P = .02) groups at 1 year. The degree of metabolic adaptation (24-hour and sleeping energy expenditure) was not significantly different between the treatment groups at either time-point. Plasma high-density lipoprotein and total and high molecular weight adiponectin were increased, and triglycerides and high-sensitivity C-reactive protein levels were reduced 1 year after RYGB or SG. CONCLUSIONS: Metabolic adaptation of approximately 150 kcal/d occurs after RYGB and SG surgery. Future studies are required to examine whether these effects remain beyond 1 year.
Authors: Michael Rosenbaum; Rochelle Goldsmith; Daniel Bloomfield; Anthony Magnano; Louis Weimer; Steven Heymsfield; Dympna Gallagher; Laurel Mayer; Ellen Murphy; Rudolph L Leibel Journal: J Clin Invest Date: 2005-12 Impact factor: 14.808
Authors: Leonie K Heilbronn; Lilian de Jonge; Madlyn I Frisard; James P DeLany; D Enette Larson-Meyer; Jennifer Rood; Tuong Nguyen; Corby K Martin; Julia Volaufova; Marlene M Most; Frank L Greenway; Steven R Smith; Walter A Deutsch; Donald A Williamson; Eric Ravussin Journal: JAMA Date: 2006-04-05 Impact factor: 56.272
Authors: Sai Krupa Das; Susan B Roberts; Megan A McCrory; L K George Hsu; Scott A Shikora; Joseph J Kehayias; Gerard E Dallal; Edward Saltzman Journal: Am J Clin Nutr Date: 2003-07 Impact factor: 7.045
Authors: Stanley Heshka; Thaisa Lemos; Nerys M Astbury; Elizabeth Widen; Lance Davidson; Bret H Goodpaster; James P DeLany; Gladys W Strain; Alfons Pomp; Anita P Courcoulas; Susan Lin; Isaiah Janumala; Wen Yu; Patrick Kang; John C Thornton; Dympna Gallagher Journal: Obes Surg Date: 2020-02 Impact factor: 4.129
Authors: Jaycob D Warfel; Bolormaa Vandanmagsar; Olga S Dubuisson; Sydney M Hodgeson; Carrie M Elks; Eric Ravussin; Randall L Mynatt Journal: Am J Physiol Regul Integr Comp Physiol Date: 2017-03-22 Impact factor: 3.619
Authors: Arnaud Sans; Laurent Bailly; Rodolphe Anty; Igor Sielezenef; Jean Gugenheim; Albert Tran; Philippe Gual; Antonio Iannelli Journal: Obes Surg Date: 2017-11 Impact factor: 4.129
Authors: Zheng Hao; R Leigh Townsend; Michael B Mumphrey; Christopher D Morrison; Heike Münzberg; Hans-Rudolf Berthoud Journal: Obes Surg Date: 2017-09 Impact factor: 4.129